Effectiveness of Truclear on Patient Quality of Life
Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the quality of life in patients treated for submucosal leiomyomas
using the Truclear hysteroscopic morcellator compared to women managed medically. Study
population includes women age 18 and older with symptomatic submucosal myomas. Patients will
be asked to complete the Uterine Myoma Symptom and Health-related Quality of Life
Questionnaire (UFS-QOL) at enrollment and at 1, 3, and 6 months after treatment.